Symbols

Symbols

GRCE

GRCE News

Newswire

08:19

FDA accepts review of GTx-104 NDA for aSAH treatment approval.

08:34

Grace Therapeutics' GTx-104 Aneurysmal Subarachnoid Hemorrhage Trial Presented at SVIN Meeting.

08:31

Grace Therapeutics Announces Presentation of Abstract at SVIN Annual Meeting: Novel GTx-104 Trial Results to be Presented.

08:35

Grace Therapeutics Raises $4M via Common Warrant Exercises

08:07

Grace Therapeutics Secures $4M in Additional Funding

About GRCE

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction